...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Still waiting for that BETonMACE CKD sub-study 7 months later

"RVX is talking about prevention of  CHF." Not really.

According to JACC:

"THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL"  (added bolding)

https://www.onlinejacc.org/content/75/11_Supplement_1/168#:~:text=Apabetalone%20(ABP)%20is%20a%20selective,congestive%20heart%20failure%20(CHF). 

Koo

Share
New Message
Please login to post a reply